FOR
IMMEDIATE RELEASE
February
4, 2009
MEDIA
CONTACT
Linda
Loren, Marketing Director, Oragenics, Inc.
727-456-0029
§
lloren@onibiopharma.com
Oragenics,
Inc., Announces Agreement
with
Garden of Life, Inc., for Use of ProBiora3
This
groundbreaking oral care probiotic ingredient will be used
in
Garden of Life products
(Alachua,
FL) The Florida-based biotechnology firm Oragenics, Inc. (OTCBB: ORNI) announces
that Garden of Life has been awarded rights to use its revolutionary oral-care
probiotic ingredient, ProBiora3. This agreement gives Garden of Life
(www.gardenoflife.com) exclusive rights to use ProBiora3 in the natural products
market. ProBiora3 is a patent-pending probiotic formula containing a blend of
three bacteria that work below the gum line to address oral health at its root
cause.
Garden of
Life is a leader in whole food nutrition, probiotics and digestive-related
products, distributing more than 65 dietary supplements. Garden of Life products
are sold at such retailers as Vitamin Shoppe and Whole Foods, and over 4,000
independent health food stores nationwide and overseas. The company is regarded
as an industry leader, consistently ranked among the top performing companies in
growth and sales by SPINS, a market research and consulting firm for the natural
products industry.
“Garden
of Life is a leading innovator in the natural products industry,” said Stanley
Stein, Oragenics’ CEO and president. “We selected this formidable company for
this exclusive relationship because we share a similar vision. Like Garden of
Life, Oragenics is passionate about helping people transform their lives and
attain extraordinary health through natural, biotechnological solutions. This is
a terrific opportunity to have an enormous impact on oral health and wellness
worldwide.”
Garden of
Life President Brian Ray said the company is dedicated to “providing the most
effective nutritional products in the world” for its customers. “This agreement
reaffirms our longstanding commitment to combine the best of nature and
science,” said Ray. “ProBiora3 is the result of many years of research and
development. This type of breakthrough technology is an example of what keeps
Garden of Life products at the top of our industry.”
ProBiora3
is a 100-percent natural ingredient that helps to re-establish a healthy balance
of oral microflora. It’s the first complete oral care probiotic blend that
supports tooth and gum health, naturally freshens breath and gently whitens
teeth.
ProBiora3
was developed by Dr. Jeffrey Hillman, D.M.D., Ph.D., and chief scientific
officer at Oragenics. It’s the result of more than 25 years of research,
which began at the Harvard-affiliated Forsyth Institute in Boston and continued
at the University of Florida. The technology has only recently become available
for the general public.
For more
information about ProBiora3, visit www.probiora3.com.
For more information about Oragenics, Inc., visit www.oragenics.com.
To
schedule an interview with Stanley Stein, contact Linda Loren at 727-456-0029;
lloren@onibiopharma.com.
About
Oragenics, Inc.
Oragenics,
Inc., is a biopharmaceutical company engaged in developing unique proprietary
technologies, some of which are being commercialized and sold in the
over-the-counter consumer healthcare market. The company also has a number of
products in discovery, preclinical and clinical development, with a
concentration in the main therapeutic area of infectious diseases, diagnostics,
and oral health. The company is located in Progress Corporate Park at
13700 Progress Boulevard in Alachua, Florida, approximately 15 miles from the
campus of the
University of Florida in Gainesville.